LEPTOPROL 5 mg, implant in a pre-filled syringe implant
Active ingredients: Leuprolide acetate, LEUPRORÉLINE
Commercialized according to BDPMDispensing in France: Prescription only
Implantimplantsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LEPTOPROL 5 mg, implant en seringue pré-remplie
- Pharmaceutical form
- implant
- Route of administration
- sous-cutanée
- Presentation description
- 1 seringue(s) préremplie(s) polycarbonate de 1 implant(s) avec aiguille(s)
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 100%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Cancer de la prostate (en traitement palliatif) ; JOURNAL OFFICIEL ; 13/03/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 14 Mar 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68594221CIP73002000CIP133400930020005Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| LEUPRORÉLINEimplant | 5 mg · un implant | FT |
| ACÉTATE DE LEUPRORÉLINEimplant | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.